GlaxoSmithKline Provides an Update on the 3-Stage Validation Approach for Lyophilized Products

Massimo Rastelli, Project Leader Biopharm, GlaxoSmithKline discusses the advancements in the freeze-drying field at SMi's 2nd annual Lyophilisation: Pharmaceuticals and Biopharmaceuticals Conference, 7-8 July, London, UK
Spread the Word
Listed Under

* Lyophilisation
* Freeze Drying
* Upscaling
* Stability
* Formulation

* Medical
* Science

* London - England - England

LONDON, England - April 17, 2014 - PRLog -- With the ever increasing cost of pharmaceutical products, the importance of research into the formulation and stability of drugs has never been higher. World renowned companies from all over the globe use research to optimise the synthesis and storage of their products through the process of lyophilisation. Biological products ranging from proteins, vaccines to other injectables must remain effective from manufacture to patient administration.

GlaxoSmithKline will be speaking at this years' Lyophilisation conference ( to provide a case study and present the latest advances in the pharmaceutical and biopharmaceutical freeze-drying field.

Highlights from the presentation entitled: 3-stage validation approach for Lyophilized products, will include:

Technology Transfer: Evaluation of an existing commercial product
Development: Establishing a new lyophilised product
Advancement: Discussion of the latest methods in the freeze-drying field

Lyophilisation 2014 will provide a mix of case study led presentations, panel debates and keynote addresses that have been tailored to an audience of professionals involved in PAT implementation, mathematical modelling, design and scale-up, to optimising and validating freeze drying life cycles. The above is just a snap shot of what will be covered at the event. To download a brochure visit (

Some of the confirmed attendees so far include: Boehringer Ingelheim, Allembis, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Norgine, Genzyme, Alexion Pharmaceuticals, Ellab, Ipsen, Ghent University, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London plus many more.

For more information and full programme details, please visit:

Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK (
For those who are interested there is currently a £100 Early Bird discount ending 30 April qbvuf available online.

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

For more information on this conference visit or alternatively contact John Collins on +44(0) 207 827 6734 or email

John Collins
+44(0) 207 827 6734
Posted By:*** Email Verified
Tags:Lyophilisation, Freeze Drying, Upscaling, Stability, Formulation
Industry:Medical, Science
Location:London - England - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Daily News
Weekly News

Like PRLog?
Click to Share